Teh‐Ying Chou

7.5k total citations
93 papers, 3.6k citations indexed

About

Teh‐Ying Chou is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Teh‐Ying Chou has authored 93 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 41 papers in Oncology and 23 papers in Molecular Biology. Recurrent topics in Teh‐Ying Chou's work include Lung Cancer Treatments and Mutations (31 papers), Lung Cancer Diagnosis and Treatment (19 papers) and Lung Cancer Research Studies (12 papers). Teh‐Ying Chou is often cited by papers focused on Lung Cancer Treatments and Mutations (31 papers), Lung Cancer Diagnosis and Treatment (19 papers) and Lung Cancer Research Studies (12 papers). Teh‐Ying Chou collaborates with scholars based in Taiwan, United States and Czechia. Teh‐Ying Chou's co-authors include Wen‐Hu Hsu, Yu–Chung Wu, Yi‐Chen Yeh, Gerald W. Hart, Jung‐Jyh Hung, Wen-Juei Jeng, Muh‐Hwa Yang, Chi V. Dang, Biing-Shiun Huang and Kou-Juey Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Teh‐Ying Chou

92 papers receiving 3.6k citations

Peers

Teh‐Ying Chou
Kah Keng Wong Malaysia
Lee Goodglick United States
Nobuhisa Ishikawa Japan
Takashi Kijima Japan
Kenzo Soejima Japan
Shigeki Shimizu Japan
Lothar Bergmann Germany
Surinder K. Batra United States
Yoichi Imai Japan
Trivadi S. Ganesan India
Kah Keng Wong Malaysia
Teh‐Ying Chou
Citations per year, relative to Teh‐Ying Chou Teh‐Ying Chou (= 1×) peers Kah Keng Wong

Countries citing papers authored by Teh‐Ying Chou

Since Specialization
Citations

This map shows the geographic impact of Teh‐Ying Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teh‐Ying Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teh‐Ying Chou more than expected).

Fields of papers citing papers by Teh‐Ying Chou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teh‐Ying Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teh‐Ying Chou. The network helps show where Teh‐Ying Chou may publish in the future.

Co-authorship network of co-authors of Teh‐Ying Chou

This figure shows the co-authorship network connecting the top 25 collaborators of Teh‐Ying Chou. A scholar is included among the top collaborators of Teh‐Ying Chou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teh‐Ying Chou. Teh‐Ying Chou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sung, Pei‐Shan, Teh‐Ying Chou, Ruey‐Bing Yang, et al.. (2021). Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection. Communications Biology. 4(1). 229–229. 8 indexed citations
2.
Wang, Mong‐Lien, Yichen Chen, Yi‐Chen Yeh, et al.. (2020). Low-Dose Nicotine Activates EGFR Signaling via α5-nAChR and Promotes Lung Adenocarcinoma Progression. International Journal of Molecular Sciences. 21(18). 6829–6829. 13 indexed citations
3.
Chen, Szu-Ting, Shu‐Mei Liang, Yi‐Chen Yeh, et al.. (2017). CLEC5A is a critical receptor in innate immunity against Listeria infection. Nature Communications. 8(1). 299–299. 73 indexed citations
4.
5.
Huang, Ben-Shian, Muh‐Hwa Yang, Peng‐Hui Wang, et al.. (2016). Oestrogen-induced angiogenesis and implantation contribute to the development of parasitic myomas after laparoscopic morcellation. Reproductive Biology and Endocrinology. 14(1). 64–64. 14 indexed citations
6.
Hung, Jung‐Jyh, Yu–Chung Wu, Teh‐Ying Chou, et al.. (2016). Adjuvant Chemotherapy Improves the Probability of Freedom From Recurrence in Patients With Resected Stage IB Lung Adenocarcinoma. The Annals of Thoracic Surgery. 101(4). 1346–1353. 42 indexed citations
7.
Hung, Jung‐Jyh, Yi‐Chen Yeh, Wen-Juei Jeng, et al.. (2015). Prognostic Factors of Survival after Recurrence in Patients with Resected Lung Adenocarcinoma. Journal of Thoracic Oncology. 10(9). 1328–1336. 34 indexed citations
8.
Chen, Cheng‐Yu, Yu–Chung Wu, Teh‐Ying Chou, & Kuang‐Yao Yang. (2013). Pleural angiosarcoma mimicking pleural haematoma. Interactive Cardiovascular and Thoracic Surgery. 17(5). 886–888. 6 indexed citations
9.
Jiang, Jeng‐Kai, Teh‐Ying Chou, Yu‐Chun Chen, et al.. (2013). Tumoral presence of human cytomegalovirus is associated with shorter disease-free survival in elderly patients with colorectal cancer and higher levels of intratumoral interleukin-17. Clinical Microbiology and Infection. 20(7). 664–671. 27 indexed citations
10.
Tang, Shye-Jye, Guang-Huan Sun, Teh‐Ying Chou, et al.. (2012). Galectin-1 Promotes Lung Cancer Progression and Chemoresistance by Upregulating p38 MAPK, ERK, and Cyclooxygenase-2. Clinical Cancer Research. 18(15). 4037–4047. 136 indexed citations
11.
Hung, Jung‐Jyh, Wen-Juei Jeng, Wen‐Hu Hsu, et al.. (2012). Prognostic Significance of the Extent of Visceral Pleural Invasion in Completely Resected Node-Negative Non-small Cell Lung Cancer. CHEST Journal. 142(1). 141–150. 34 indexed citations
12.
Hung, Jung‐Jyh, Wen-Juei Jeng, Wen‐Hu Hsu, et al.. (2012). Predictors of Death, Local Recurrence, and Distant Metastasis in Completely Resected Pathological Stage-I Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 7(7). 1115–1123. 96 indexed citations
13.
Chen, Yuh-Min, Chun-Ming Tsai, Shih-Hao Liu, et al.. (2011). A Phase II Randomized Trial of Gefitinib Alone or with Tegafur/Uracil Treatment in Patients with Pulmonary Adenocarcinoma Who had Failed Previous Chemotherapy. Journal of Thoracic Oncology. 6(6). 1110–1116. 23 indexed citations
14.
Chen, Yuh-Min, Chun-Ming Tsai, Jen-Fu Shih, et al.. (2011). Phase II Randomized Trial of Erlotinib or Vinorelbine in Chemonaive, Advanced, Non-small Cell Lung Cancer Patients Aged 70 Years or Older. Journal of Thoracic Oncology. 7(2). 412–418. 51 indexed citations
15.
Hung, Jan‐Jong, Wen‐Juei Jeng, W. H. Hsu, et al.. (2010). Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis. Thorax. 65(3). 241–245. 61 indexed citations
16.
Chen, Cheng‐Yu, Kuang‐Yao Yang, Mei‐Yu Chen, et al.. (2009). Decoy Receptor 3 Levels in Peripheral Blood Predict Outcomes of Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 180(8). 751–760. 36 indexed citations
17.
Kuo, Kuang-Tai, Hao‐Wei Wang, Teh‐Ying Chou, et al.. (2008). Prognostic Role of PGE2 Receptor EP2 in Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 16(2). 352–360. 28 indexed citations
18.
Chang, Gee‐Chen, Ko‐Jiunn Liu, Chia‐Ling Hsieh, et al.. (2006). Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes. Clinical Cancer Research. 12(19). 5746–5754. 128 indexed citations
19.
Chou, Teh‐Ying, et al.. (2000). Well-differentiated fetal adenocarcinoma of the lung.. PubMed. 99(5). 425–7.
20.
Roquemore, Elizabeth P., Teh‐Ying Chou, & Gerald W. Hart. (1994). [26] Detection of O-Linked N-acetylglucosamine (O-GlcNAc) on cytoplasmic and nuclear proteins. Methods in enzymology on CD-ROM/Methods in enzymology. 230. 443–460. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kah Keng Wong Breakdown of academic impact, for papers by Lee Goodglick Breakdown of academic impact, for papers by Nobuhisa Ishikawa Breakdown of academic impact, for papers by Takashi Kijima Breakdown of academic impact, for papers by Kenzo Soejima Breakdown of academic impact, for papers by Shigeki Shimizu Breakdown of academic impact, for papers by Lothar Bergmann Breakdown of academic impact, for papers by Surinder K. Batra Breakdown of academic impact, for papers by Yoichi Imai Breakdown of academic impact, for papers by Trivadi S. Ganesan
Rankless by CCL
2026